• Pamplona Capital to take Parexel private in $5B cash deal - New Jersey Herald

    Pamplona Capital to take Parexel private in $5B cash deal - New Jersey Herald
    New Jersey Herald
    Pamplona Capital to take Parexel private in $5B cash deal
    New Jersey Herald
    Parexel is being acquired by Pamplona Capital Management in a $5 billion deal that will make the pharmaceutical contract researcher a private company. The private equity fund manager said Tuesday that it will pay $88.10 for each share, which represents ...y más »
  • PAREXEL Announces Acquisition by Pamplona Capital for $5B - Nasdaq

    PAREXEL Announces Acquisition by Pamplona Capital for $5B - Nasdaq
    Nasdaq
    PAREXEL Announces Acquisition by Pamplona Capital for $5B
    Nasdaq
    PAREXEL International CorporationPRXL , a global biopharmaceutical services company and provider of clinical research and logistics, recently announced that it has agreed to be acquired by Pamplona Capital Management, LLP. The transaction is valued ...
    Parexel acquired by Pamplona Capital - Outsourcing-Pharma.comOutSourcing-Pharma.com
    Pamplona Capital Management nears deal to buy Parexel - WSJ ...Reuters
    Pamplona Fund
  • A closer look at the Parexel deal - OutSourcing-Pharma.com

    A closer look at the Parexel deal - OutSourcing-Pharma.com
    OutSourcing-Pharma.com
    A closer look at the Parexel deal
    OutSourcing-Pharma.com
    Another day, another CRO acquisition – this time Parexel, a top 10 CRO, was acquired by Pamplona Capital, a large private equity firm. Last month, I speculated on Outsourcing-Pharma.com that it was possible that we could see a merger between either ...
    Pamplona Capital Management nears deal to buy Parexel - WSJReuterslos 7 artículos informativos »